Synopsys's 15min chart signals MACD Death Cross and KDJ Death Cross.

Synopsys's 15-minute chart has recently triggered a MACD Death Cross and a KDJ Death Cross, both of which occurred on 09/02/2025 at 09:45. This technical indicator suggests that the stock price is poised to continue its downward trend, as the momentum of the stock price is shifting towards the downside and may experience further decreases in value.

Synopsys Inc. (SNPS) has recently experienced a significant shift in its stock price momentum, as indicated by the appearance of a MACD Death Cross and a KDJ Death Cross on its 15-minute chart. These technical signals, both occurring on September 2, 2025, at 09:45, suggest that the stock price is poised to continue its downward trend, with potential for further decreases in value.

The MACD (Moving Average Convergence Divergence) Death Cross is a bearish signal that occurs when the MACD line crosses below the signal line. The KDJ (Kaufman Adaptive Moving Average) Death Cross is another bearish indicator, which appears when the KDJ line crosses below the signal line. These technical indicators are widely used to gauge the momentum of a stock and predict potential price movements.

Synopsys has been under pressure in recent weeks, with a 3.65% drop in its stock price [1]. This decline is attributed to new U.S. export restrictions on semiconductor design software, which have forced the company to halt sales in China, potentially impacting near-term revenue. The regulatory environment remains a key risk factor for the sector, with peers like Siemens EDA and Cadence Design Systems also affected [1].

Technically, the picture for Synopsys is weak. The Williams %R Oversold indicator has appeared five times in the last five days, suggesting the stock may be overbought or oversold without clear direction [1]. Additionally, a Bearish Marubozu pattern and a KDJ Death Cross emerged on August 29, 2025, at 12:00, indicating a shift in momentum towards the downside [2]. These technical signals suggest that sellers are currently dominating the market, and bearish momentum is likely to continue.

Institutional inflows have been positive, with large and extra-large fund flows showing positive inflow ratios [1]. However, these flows have not translated into immediate price strength, indicating that investor confidence is still under pressure from broader market factors [1]. Given the regulatory uncertainty, weak technical signals, and mixed analyst ratings, Synopsys is not currently in a favorable position for short-term buyers. The internal diagnostic score of 3.66 and recent bearish chart patterns suggest that it may be wise to wait for a clearer trend or more definitive signals before committing [2].

Investors should consider holding off for clarity and stability, watching for any follow-up on the U.S. export policy and earnings reports for potential catalysts. The bearish export-related news and mixed analyst ratings further add to the uncertainty.

References:
[1] https://www.ainvest.com/news/stock-analysis-synopsys-outlook-cautious-view-regulatory-technical-headwinds-2508/
[2] https://www.ainvest.com/news/stock-analysis-synopsys-outlook-technical-weakness-regulatory-headwinds-cloud-short-term-prospects-2508/